Italia markets closed

BMY Dec 2024 50.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,5000+0,0100 (+2,04%)
In data: 03:04PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,4900
Aperto0,4800
Denaro0,4500
Domanda0,6800
Prezzo d'esercizio50,00
Scadenza2024-12-20
Min-Max giorno0,4800 - 0,5100
Contratto - Min-MaxN/D
Volume22
Open Interest1,65k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri